GlassScriptPhysician profile
Olivia Michaels
NPI 1316408917
$9,156.21
in general payments reported to CMS, 2019-2025
33 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,673 · 2022: $3,040 · 2023: $1,247 · 2024: $1,800 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,443.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,377.83 | 2021-2025 | Proclaim, Octrode, Axium |
| Abbvie INC. | $957.49 | 2021-2025 | |
| Si-Bone, INC. | $515.27 | 2022-2025 | |
| Saluda Medical Americas, INC. | $420.10 | 2024-2025 | Evoke |
| Spr Therapeutics, INC | $398.76 | 2023-2025 | Sprint Pns System |
| Merz Pharmaceuticals, LLC | $388.73 | 2021-2025 | Xeomin |
| Horizon Therapeutics Plc | $364.98 | 2021-2022 | |
| Painteq LLC | $197.48 | 2023 | Painteq |
| Nevro Corp. | $158.26 | 2022-2023 | Senza |
| Stryker Corporation | $146.37 | 2024 | Mild Device Kit |
| Genentech USA, INC. | $140.40 | 2021 | |
| Amgen INC. | $124.99 | 2021 | |
| Novo Nordisk INC | $124.98 | 2022 | |
| Edwards Lifesciences Corporation | $114.60 | 2021 | |
| Revance Therapeutics, INC. | $106.07 | 2024-2025 | Daxxify |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $92.05 | 2021 | |
| Axsome Therapeutics, INC. | $57.12 | 2025 | Symbravo |
| Ipsen Biopharmaceuticals, INC | $57.02 | 2024-2025 | Dysport |
| Novartis Pharmaceuticals Corporation | $53.75 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $40.90 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $33.69 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.53 | 2021 | |
| Curonix LLC | $30.93 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Foundation Fusion Solutions, LLC | $30.85 | 2024 | |
| Bioventus LLC | $28.70 | 2024 | Durolane |
| Pfizer INC. | $27.63 | 2021 | |
| Fidia Pharma USA INC. | $23.32 | 2023 | Hymovis, Triluron |
| Xeris Pharmaceuticals, INC. | $22.08 | 2024 | Keveyis |
| Pacira Pharmaceuticals Incorporated | $21.73 | 2023 | Iovera, Zilretta |
| Botanix Sb INC | $19.27 | 2025 | Sofdra |
| E.R. Squibb & Sons, L.L.C. | $18.36 | 2021 | |
| Mdd US Operations, LLC | $17.96 | 2021 | |
| Galderma Laboratories, L.P. | $13.01 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Michaels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.